1. Home
  2. OMER
  3. OMER News

Latest Omeros Corporation (OMER) News on May 20, 2025

OMER

Thomson Reuters StreetEvents

4 days ago

Q1 2025 Omeros Corp Earnings Call

Omeros Corp (OMER) Q1 2025 Earnings Call Highlights: Strategic Debt Reduction and Narsoplimab ...
OMER

GuruFocus.com

4 days ago

Omeros Corp (OMER) Q1 2025 Earnings Call Highlights: Strategic Debt Reduction and Narsoplimab ...

OMER

Associated Press Finance

4 days ago

Omeros: Q1 Earnings Snapshot

Omeros Corporation Reports First Quarter 2025 Financial Results
OMER

Business Wire

4 days ago

Omeros Corporation Reports First Quarter 2025 Financial Results

Omeros Corporation to Announce First Quarter Financial Results on May 15, 2025
OMER

Business Wire

7 days ago

Omeros Corporation to Announce First Quarter Financial Results on May 15, 2025

OMER

MT Newswires

7 days ago

Top Midday Decliners

OMER

MT Newswires

8 days ago

Omeros to Exchange 2026 Convertible Notes for New 2029 Notes

Omeros Corporation Announces Agreements to Acquire $80.5 Million of its Convertible Senior Notes Due 2026
OMER

Business Wire

8 days ago

Omeros Corporation Announces Agreements to Acquire $80.5 Million of its Convertible Senior Notes Due 2026

FDA Accepts Resubmission of BLA for Narsoplimab for Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy (TA-TMA) and Assigns Late September PDUFA Date
OMER

Business Wire

14 days ago

FDA Accepts Resubmission of BLA for Narsoplimab for Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy (TA-TMA) and Assigns Late September PDUFA Date

Omeros Announces the Omeros Oncology Clinical Steering Committee for AML to Help Guide Omeros’ Proprietary OncotoX-AML Clinical Program
OMER

Business Wire

a month ago

Omeros Announces the Omeros Oncology Clinical Steering Committee for AML to Help Guide Omeros’ Proprietary OncotoX-AML Clinical Program

Omeros Corporation To Introduce Its Proprietary T-CAT™ Program for the Treatment of Multidrug-Resistant Pathogens in Plenary Session at Upcoming European Congress on Infectious Diseases
OMER

Business Wire

a month ago

Omeros Corporation To Introduce Its Proprietary T-CAT™ Program for the Treatment of Multidrug-Resistant Pathogens in Plenary Session at Upcoming European Congress on Infectious Diseases

OMER

Thomson Reuters StreetEvents

2 months ago

Q4 2024 Omeros Corp Earnings Call

Omeros Corp (OMER) Q4 2024 Earnings Call Highlights: Navigating Financial Challenges with ...
OMER

GuruFocus.com

2 months ago

Omeros Corp (OMER) Q4 2024 Earnings Call Highlights: Navigating Financial Challenges with ...

OMER

Associated Press Finance

2 months ago

Omeros: Q4 Earnings Snapshot

Omeros Corporation Reports Fourth Quarter and Year-End 2024 Financial Results
OMER

Business Wire

2 months ago

Omeros Corporation Reports Fourth Quarter and Year-End 2024 Financial Results

Omeros Corporation to Announce Fourth Quarter and Year-end Financial Results on March 31, 2025
OMER

Business Wire

2 months ago

Omeros Corporation to Announce Fourth Quarter and Year-end Financial Results on March 31, 2025

Omeros to activate site for Phase III programme of zaltenibart for PNH
OMER

Clinical Trials Arena

2 months ago

Omeros to activate site for Phase III programme of zaltenibart for PNH

OMER

MT Newswires

2 months ago

Omeros Says Trial Site Activation Underway for Phase 3 Study of Zaltenibart

Omeros Corporation Provides Update of Ongoing Zaltenibart Phase 3 PNH Clinical Trial Program
OMER

Business Wire

2 months ago

Omeros Corporation Provides Update of Ongoing Zaltenibart Phase 3 PNH Clinical Trial Program

Omeros Corporation Receives Commitment of Over $4 Million from NIDA for Further Development of the Company’s OMS527 Program to Treat Cocaine Use Disorder
OMER

Business Wire

2 months ago

Omeros Corporation Receives Commitment of Over $4 Million from NIDA for Further Development of the Company’s OMS527 Program to Treat Cocaine Use Disorder

Omeros announces results for narsoplimab expanded access program
OMER

TipRanks

3 months ago

Omeros announces results for narsoplimab expanded access program

Omeros Announces Robust Results for Narsoplimab Expanded Access Program in TA-TMA
OMER

Business Wire

3 months ago

Omeros Announces Robust Results for Narsoplimab Expanded Access Program in TA-TMA

Omeros Corporation Announces Availability on its Website of Materials Accompanying Narsoplimab Presentations at the 2025 Tandem Meetings
OMER

Business Wire

3 months ago

Omeros Corporation Announces Availability on its Website of Materials Accompanying Narsoplimab Presentations at the 2025 Tandem Meetings

Omeros Corporation Announces Upcoming Presentations Detailing Outcomes of Narsoplimab Treatment for TA-TMA Under an Expanded Access Program
OMER

Business Wire

3 months ago

Omeros Corporation Announces Upcoming Presentations Detailing Outcomes of Narsoplimab Treatment for TA-TMA Under an Expanded Access Program

Institutions own 43% of Omeros Corporation (NASDAQ:OMER) shares but retail investors control 53% of the company
OMER

Simply Wall St.

3 months ago

Institutions own 43% of Omeros Corporation (NASDAQ:OMER) shares but retail investors control 53% of the company

OMER

MT Newswires

4 months ago

New Analysis of Omeros' Narsoplimab to Treat Complications From Stem Cell Transplant Support Results

Omeros Announces Update on Statistical Analysis of Narsoplimab Pivotal Trial Primary Endpoint
OMER

Business Wire

4 months ago

Omeros Announces Update on Statistical Analysis of Narsoplimab Pivotal Trial Primary Endpoint

When Can We Expect A Profit From Omeros Corporation (NASDAQ:OMER)?
OMER

Simply Wall St.

5 months ago

When Can We Expect A Profit From Omeros Corporation (NASDAQ:OMER)?

OMER

MT Newswires

5 months ago

Sector Update: Health Care Stocks Lower Thursday Afternoon

OMER

MT Newswires

5 months ago

Top Midday Gainers

Omeros Reports Narsoplimab TA-TMA Trial Success; Stock Surges
OMER

GuruFocus.com

5 months ago

Omeros Reports Narsoplimab TA-TMA Trial Success; Stock Surges

OMER

MT Newswires

5 months ago

Omeros' Pivotal Trial of Narsoplimab Meets Primary Endpoint

Omeros’ Narsoplimab Meets its Pivotal Trial Primary Endpoint – Statistical Analysis Shows Survival Superiority Over External Control in Patients with TA-TMA
OMER

Business Wire

5 months ago

Omeros’ Narsoplimab Meets its Pivotal Trial Primary Endpoint – Statistical Analysis Shows Survival Superiority Over External Control in Patients with TA-TMA

Omeros Corp (OMER): Profit-Taking Time Amid ASH Presentations and Financial Challenges
OMER

Insider Monkey

5 months ago

Omeros Corp (OMER): Profit-Taking Time Amid ASH Presentations and Financial Challenges

Omeros Corporation Announces Presentation of Positive Zaltenibart Data at ASH Annual Meeting
OMER

Business Wire

5 months ago

Omeros Corporation Announces Presentation of Positive Zaltenibart Data at ASH Annual Meeting

Omeros Corporation Announces Upcoming Presentations at ASH Annual Meeting
OMER

Business Wire

6 months ago

Omeros Corporation Announces Upcoming Presentations at ASH Annual Meeting

Omeros Updates Progress on Narsoplimab Biologics License Resubmission; Stock up Over 30% on News
OMER

GuruFocus.com

6 months ago

Omeros Updates Progress on Narsoplimab Biologics License Resubmission; Stock up Over 30% on News

Omeros Corporation Provides Update on Progress Toward BLA Resubmission
OMER

Business Wire

6 months ago

Omeros Corporation Provides Update on Progress Toward BLA Resubmission

OMER

Thomson Reuters StreetEvents

6 months ago

Q3 2024 Omeros Corp Earnings Call

Omeros Corp (OMER) Q3 2024 Earnings Call Highlights: Strategic Advances Amid Financial Adjustments
OMER

GuruFocus.com

6 months ago

Omeros Corp (OMER) Q3 2024 Earnings Call Highlights: Strategic Advances Amid Financial Adjustments

OMER

Associated Press Finance

6 months ago

Omeros: Q3 Earnings Snapshot

Omeros Corporation Reports Third Quarter 2024 Financial Results
OMER

Business Wire

6 months ago

Omeros Corporation Reports Third Quarter 2024 Financial Results

Omeros Corporation to Announce Third Quarter Financial Results on November 13, 2024
OMER

Business Wire

6 months ago

Omeros Corporation to Announce Third Quarter Financial Results on November 13, 2024

OMER

MT Newswires

7 months ago

Omeros Gets FDA Rare Pediatric Disease Designation for Kidney Disease Drug Candidate

Retail investors account for 52% of Omeros Corporation's (NASDAQ:OMER) ownership, while institutions account for 43%
OMER

Simply Wall St.

9 months ago

Retail investors account for 52% of Omeros Corporation's (NASDAQ:OMER) ownership, while institutions account for 43%

OMER

Associated Press Finance

9 months ago

Omeros: Q2 Earnings Snapshot

Omeros Corporation Reports Second Quarter 2024 Financial Results
OMER

Business Wire

9 months ago

Omeros Corporation Reports Second Quarter 2024 Financial Results

Omeros Corporation to Announce Second Quarter Financial Results on August 7, 2024
OMER

Business Wire

9 months ago

Omeros Corporation to Announce Second Quarter Financial Results on August 7, 2024

Edge Total Intelligence Inc. Updates Status of MCTO
OMER

Newsfile

a year ago

Edge Total Intelligence Inc. Updates Status of MCTO

Hofseth Biocare ASA: AGREES CHINA DISTRIBUTION PARTNERSHIP WITH SHANGHAI-BASED LITHY
OMER

GlobeNewswire

a year ago

Hofseth Biocare ASA: AGREES CHINA DISTRIBUTION PARTNERSHIP WITH SHANGHAI-BASED LITHY

HEATHERWICK STUDIO UNVEILS ICONIC GLASS CANOPY, THE JEWEL IN THE CROWN OF REIMAGINED OLYMPIA
OMER

CNW Group

a year ago

HEATHERWICK STUDIO UNVEILS ICONIC GLASS CANOPY, THE JEWEL IN THE CROWN OF REIMAGINED OLYMPIA

LED Driver with CAN Bus for Dynamic Automotive Interior RGB Lighting
OMER

GlobeNewswire

a year ago

LED Driver with CAN Bus for Dynamic Automotive Interior RGB Lighting

Hyundai Motor Presents Its First Film 'Night Fishing' in Collaboration with K-Movie Star Son Sukku
OMER

CNW Group

a year ago

Hyundai Motor Presents Its First Film 'Night Fishing' in Collaboration with K-Movie Star Son Sukku

The sale of Aspo's subsidiary ESL Shipping's Supramax vessels has been completed on June 11 2024
OMER

GlobeNewswire

a year ago

The sale of Aspo's subsidiary ESL Shipping's Supramax vessels has been completed on June 11 2024

Nokia introduces Network Exposure Platform to expand and simplify network API exposure for service providers
OMER

GlobeNewswire

a year ago

Nokia introduces Network Exposure Platform to expand and simplify network API exposure for service providers

IMAGO AIOS Prime Clinches Red Dot Award for 2024, Expands US Footprint with New Boston Warehouse
OMER

PR Newswire

a year ago

IMAGO AIOS Prime Clinches Red Dot Award for 2024, Expands US Footprint with New Boston Warehouse

Omeros Announces Webcast Details for Annual Meeting of Shareholders
OMER

Business Wire

a year ago

Omeros Announces Webcast Details for Annual Meeting of Shareholders

Omeros Corporation Further Strengthens its Balance Sheet through Series of Financing Transactions Extending Maturity on a Majority of its Outstanding Debt into 2028
OMER

Business Wire

a year ago

Omeros Corporation Further Strengthens its Balance Sheet through Series of Financing Transactions Extending Maturity on a Majority of its Outstanding Debt into 2028

OMER

Thomson Reuters StreetEvents

a year ago

Q1 2024 Omeros Corp Earnings Call

OMER

GuruFocus.com

a year ago

Omeros Corp (OMER) Q1 2024 Earnings Call Transcript Highlights: Financial Shifts and Strategic ...

OMER

Associated Press Finance

a year ago

Omeros: Q1 Earnings Snapshot

Omeros Corporation Reports First Quarter 2024 Financial Results
OMER

Business Wire

a year ago

Omeros Corporation Reports First Quarter 2024 Financial Results

Omeros Corporation to Announce First Quarter Financial Results on May 15, 2024
OMER

Business Wire

a year ago

Omeros Corporation to Announce First Quarter Financial Results on May 15, 2024

Omeros Corporation Announces Upcoming Presentations at 2024 European Hematology Association (EHA) Hybrid Congress
OMER

Business Wire

a year ago

Omeros Corporation Announces Upcoming Presentations at 2024 European Hematology Association (EHA) Hybrid Congress

OMER

Thomson Reuters StreetEvents

a year ago

Q4 2023 Omeros Corp Earnings Call

Omeros Corporation (NASDAQ:OMER) Q4 2023 Earnings Call Transcript
OMER

Insider Monkey

a year ago

Omeros Corporation (NASDAQ:OMER) Q4 2023 Earnings Call Transcript

OMER

GuruFocus.com

a year ago

Omeros Corp (OMER) Reports Fourth Quarter and Year-End 2023 Financial Results

OMER

Associated Press Finance

a year ago

Omeros: Q4 Earnings Snapshot

Omeros Corporation Reports Fourth Quarter and Year-End 2023 Financial Results
OMER

Business Wire

a year ago

Omeros Corporation Reports Fourth Quarter and Year-End 2023 Financial Results

Omeros Corporation to Announce Fourth Quarter and Year-End Financial Results on April 1, 2024
OMER

Business Wire

a year ago

Omeros Corporation to Announce Fourth Quarter and Year-End Financial Results on April 1, 2024

Omeros Corporation Announces Upcoming Presentation Detailing Narsoplimab Compassionate Use in Nine Patients with Hematopoietic Stem Cell Transplant-associated Thrombotic Microangiopathy
OMER

Business Wire

a year ago

Omeros Corporation Announces Upcoming Presentation Detailing Narsoplimab Compassionate Use in Nine Patients with Hematopoietic Stem Cell Transplant-associated Thrombotic Microangiopathy

3 Sleeper Stocks Under $15 Ready to Explode by 2029
OMER

InvestorPlace

a year ago

3 Sleeper Stocks Under $15 Ready to Explode by 2029

Omeros Corporation Announces Additional Royalty Monetization with DRI Healthcare Trust
OMER

Business Wire

a year ago

Omeros Corporation Announces Additional Royalty Monetization with DRI Healthcare Trust

3 Basic Materials Stocks to Sell as the Commodity Cycle Turns in 2024
OMER

InvestorPlace

a year ago

3 Basic Materials Stocks to Sell as the Commodity Cycle Turns in 2024

Abbott (ABT) Q4 Earnings Match Estimates
OMER

Zacks

a year ago

Abbott (ABT) Q4 Earnings Match Estimates

OMER

Business Wire

a year ago

Xperi Launches First UK In-Car Entertainment Report, Consumers Call for a Personalised Entertainment Dash

Institutions profited after Omeros Corporation's (NASDAQ:OMER) market cap rose US$23m last week but individual investors profited the most
OMER

Simply Wall St.

a year ago

Institutions profited after Omeros Corporation's (NASDAQ:OMER) market cap rose US$23m last week but individual investors profited the most

Favourable Signals For Hamilton Beach Brands Holding: Numerous Insiders Acquired Stock
OMER

Simply Wall St.

a year ago

Favourable Signals For Hamilton Beach Brands Holding: Numerous Insiders Acquired Stock

Zacks Value Investor Highlights: Potbelly, Xperi, Virco, Enviri and Anywhere Real Estate
OMER

Zacks

a year ago

Zacks Value Investor Highlights: Potbelly, Xperi, Virco, Enviri and Anywhere Real Estate

Best Momentum Stock to Buy for January 19th
OMER

Zacks

a year ago

Best Momentum Stock to Buy for January 19th

Bar Harbor Bankshares Declares Quarterly Cash Dividend
OMER

ACCESSWIRE

a year ago

Bar Harbor Bankshares Declares Quarterly Cash Dividend

Rackspace Introduces Intelligent Co-worker for the Enterprise Accelerator on AWS Marketplace
OMER

GlobeNewswire

a year ago

Rackspace Introduces Intelligent Co-worker for the Enterprise Accelerator on AWS Marketplace

Anavex Life Sciences Announces U.S. Phase 2 Clinical Trial of ANAVEX®3-71 in Schizophrenia
OMER

GlobeNewswire

a year ago

Anavex Life Sciences Announces U.S. Phase 2 Clinical Trial of ANAVEX®3-71 in Schizophrenia

Talkspace to Present at the 26th Annual Needham Growth Conference
OMER

GlobeNewswire

a year ago

Talkspace to Present at the 26th Annual Needham Growth Conference

Zacks.com featured highlights include Aspen Aerogels, AxoGen and Credo Technology Group
OMER

Zacks

a year ago

Zacks.com featured highlights include Aspen Aerogels, AxoGen and Credo Technology Group

Zacks Value Trader Highlights: Deluxe, KT, Liberty Energy, OPENLANE and Toyota Motor
OMER

Zacks

a year ago

Zacks Value Trader Highlights: Deluxe, KT, Liberty Energy, OPENLANE and Toyota Motor

Nexxen to Present at the Needham Growth Conference
OMER

GlobeNewswire

a year ago

Nexxen to Present at the Needham Growth Conference

Wolverine Worldwide Sells Sperry
OMER

Business Wire

a year ago

Wolverine Worldwide Sells Sperry

OMER

Zacks

a year ago

Brian's Big Idea on Biotech

Shattuck Labs Announces Presentation at Upcoming 42nd Annual J.P. Morgan Healthcare Conference
OMER

GlobeNewswire

a year ago

Shattuck Labs Announces Presentation at Upcoming 42nd Annual J.P. Morgan Healthcare Conference

Clearfield to Present at the Needham Growth Conference
OMER

Business Wire

a year ago

Clearfield to Present at the Needham Growth Conference

TeraWulf Announces December 2023 Production and Operations Updates
OMER

GlobeNewswire

a year ago

TeraWulf Announces December 2023 Production and Operations Updates

OMER

Business Wire

a year ago

Black Rifle Coffee Company to Participate in the 2024 ICR Conference

APi Group Corporation (APG) Soars to 52-Week High, Time to Cash Out?
OMER

Zacks

a year ago

APi Group Corporation (APG) Soars to 52-Week High, Time to Cash Out?

Great Lakes Announces Receipt of $173.7 Million in Awarded Work
OMER

GlobeNewswire

a year ago

Great Lakes Announces Receipt of $173.7 Million in Awarded Work

OMER

GlobeNewswire

a year ago

Puyi Announces Share Exchange Transactions with Certain Shareholders of Fanhua

FANHUA Announces Share Exchange Transaction Between Certain Shareholders and Puyi Inc.
OMER

GlobeNewswire

a year ago

FANHUA Announces Share Exchange Transaction Between Certain Shareholders and Puyi Inc.

Axogen, Inc. Appoints Kathy Weiler to its Board of Directors
OMER

GlobeNewswire

a year ago

Axogen, Inc. Appoints Kathy Weiler to its Board of Directors

Calavo Growers Insiders Placed Bullish Bets Worth US$4.98m
OMER

Simply Wall St.

a year ago

Calavo Growers Insiders Placed Bullish Bets Worth US$4.98m

7 Short-Squeeze Stocks That Are Screaming for Speculation
OMER

InvestorPlace

a year ago

7 Short-Squeeze Stocks That Are Screaming for Speculation

Share on Social Networks: